Pharma CFOs key to driving growth: E&Y

April 2008
Chemical Business;Apr2008, Vol. 22 Issue 4, p92
Trade Publication
The article reports on the findings of a survey conducted by global consultancy company Ernst & Young (E&Y), which state that the role of chief financial officers (CFOs) in the pharmaceutical sector in India is undergoing a change and they will have to be more proactive than before as firms seek ambitious growth strategies. The study cites that majority of respondents felt improving respondents value and responsiveness to business needs were among the drivers of the change in the pharmaceutical sector.


Related Articles

  • More CFOs getting on board.  // CMA Magazine (1926-4550);Mar/Apr2013, Vol. 87 Issue 2, p9 

    The article focuses on the result of the survey "CFO and Beyond: The Possibilities and Pathways Outside Finance" from Ernst and Young which shows that almost eight in 10 chief financial officers (CFOs) say that they are a popular choice for boardlevel roles due to their financial expertise.

  • A New Role.  // Pharmaceutical Executive;May2008, Vol. 28 Issue 5, p28 

    The article reports on the findings of the study conducted by Ernst & Young LLC which assesses the responsibilities of chief financial officers (CFOs) in the pharmaceutical industry in the U.S. The study reveals that CFOs are more concern on the improvement of internal business processes and...

  • Making better decisions tomorrow. Ang, Benjamin // Asia Insurance Review;Jun2015, p60 

    The article discusses the highlights of the "Global Insurance Chief Financial Officer (CFO) Survey" conducted by multinational professional services firm Ernst and Young (EY) to determine key CFO functions that need improvement in financial and actuarial organizations. Topics covered include the...

  • Strength in numbers. DONGOSKI, ROB // Smart Business Chicago;Mar2014, Vol. 11 Issue 4, p6 

    The article focuses on the survey "Partnering for Performance: CFO (chief financial officer) and the Supply Chain" conducted by legal consultancy Ernst and Young LLP on the impact of the collaboration of CFO and chief supply chain officers on the business, as of March 2014. Topics include the...

  • A tough balancing act.  // Banker Middle East;Feb2012, Issue 137, p38 

    The article discusses about the role of chief financial officers (CFOs) in balancing investments and managing risk in diverse markets, focusing on a survey from professional services company Ernst & Young. Topics include balancing resource allocation between rapid-growth and developed markets,...

  • ERNST & YOUNG REPORT: MEDIA COMPANY CFOS EMBRACING DIGITAL. TRIBBEY, CHRIS // Home Media Magazine;8/18/2014, Vol. 36 Issue 22, p12 

    The article presents a report of the professional service firm Ernst and Young as of August 2014 which shows the concern of chief financial officers (CFOs) from media and entertainment firms including Dream Works Animation, Sony Pictures Entertainment and DirecTV, for digital growth.

  • Ernst & Young survey finds counterfeiting fight is a priority.  // Long Island Business News (7/1993 to 5/2009);5/13/2005, Vol. 52 Issue 20, p8B 

    Reports that many pharmaceutical companies are taking steps to better control the distribution of drugs, cutting off suppliers that violate contracts and tapping technology to battle counterfeiting according to a study by Ernst and Young in the U.S. Percentage of pharmaceutical firms that...

  • Survey: Outsourcing Considered by Pharma. Gaudio, Thomas // njbiz;3/31/2008, Vol. 21 Issue 14, p2 

    The article reports on the findings of a survey by Ernst & Young which revealed that pharmaceutical firms are more likely to consider outsourcing to cut costs than executives from other industries. The survey found that 64 percent of chief-level and board-level executives at worldwide drug...

  • Pharma majors banking on India, other emerging markets for growth: Report.  // Chemical Business;Dec2008, Vol. 22 Issue 12, p46 

    The article reports on the findings of a global survey of top pharmaceutical companies conducted by Ernst & Young regarding the success of pharmaceutical firms in emerging markets. The survey found that global drug firms are depending on these markets to extend the life of their mature products...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics